FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894524500> ?p ?o ?g. }

• W2894524500 endingPage "737" @default.
• W2894524500 startingPage "731" @default.
• W2894524500 abstract "Postmenopausal women receive bisphosphonates for osteoporosis treatment. The effect of these medications on developing diabetes mellitus in prediabetic patients is yet to be investigated. We aimed to determine the effect of alendronate on plasma glucose, insulin indices of postmenopausal women with prediabetes and osteopenia.The present triple-blind randomized controlled clinical trial included 60 postmenopausal women, aged 45-60 years. All patients were vitamin D sufficient. They were randomly enrolled in intervention (70 mg/week alendronate for 12 weeks) and control (placebo tablet per week for 12 weeks) groups. The morning 8-h fasting blood samples were collected at the baseline and follow-up visits to measure the fasting plasma glucose (mg/dL), insulin and hemoglobin A1c (HbA1c). Plasma glucose and insulin concentration were measured 30, 60 and 120 min after the glucose tolerance test. The Matsuda Index, homeostasis model assessment of insulin resistance, homeostasis model assessment of β-cell function and the area under the curves of glucose and insulin were calculated.The mean (standard deviation) fasting plasma glucose (102.43 [1.46] mg/dL vs 94.23 [1.17] mg/dL, P = 0.001), 120-min insulin concentration (101.86 [15.70] mU/L vs 72.60 [11.36] mU/L, P = 0.026), HbA1c (5.60 [0.06]% vs 5.40 [0.05]%, P = 0.001), homeostasis model assessment of insulin resistance (3.57 [0.45] vs 2.62 [0.24], P = 0.021) and Matsuda Index (7.7 [0.41] vs 9.2 [0.4], P = 0.001) significantly improved in the alendronate-treated group. There were more statistically significant reductions in fasting plasma glucose (-8.2 [8.63] mg/dL vs -2.5 [14.26] mg/dL, P = 0.002) and HbA1c (-0.2 [0.23]% vs -0.09 [0.26]%, P = 0.015) observed in the alendronate-treated group than the placebo group during the study course, respectively.Administration of 70 mg/week alendronate improves fasting plasma glucose, HbA1c and insulin indices in postmenopausal women." @default.
• W2894524500 created "2018-10-05" @default.
• W2894524500 creator A5016811241 @default.
• W2894524500 creator A5017181473 @default.
• W2894524500 creator A5020894018 @default.
• W2894524500 creator A5034851576 @default.
• W2894524500 creator A5041896485 @default.
• W2894524500 creator A5050955864 @default.
• W2894524500 creator A5063831864 @default.
• W2894524500 creator A5066611740 @default.
• W2894524500 creator A5076190542 @default.
• W2894524500 date "2018-10-23" @default.
• W2894524500 modified "2023-10-16" @default.
• W2894524500 title "Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial" @default.
• W2894524500 cites W1501939485 @default.
• W2894524500 cites W1922572604 @default.
• W2894524500 cites W1971400919 @default.
• W2894524500 cites W1980468305 @default.
• W2894524500 cites W1980740451 @default.
• W2894524500 cites W1986630057 @default.
• W2894524500 cites W1993701679 @default.
• W2894524500 cites W1999287713 @default.
• W2894524500 cites W1999796786 @default.
• W2894524500 cites W2011893223 @default.
• W2894524500 cites W2015050458 @default.
• W2894524500 cites W2025672294 @default.
• W2894524500 cites W2029330864 @default.
• W2894524500 cites W2031370419 @default.
• W2894524500 cites W2047761422 @default.
• W2894524500 cites W2054134119 @default.
• W2894524500 cites W2075749036 @default.
• W2894524500 cites W2078669300 @default.
• W2894524500 cites W2095543479 @default.
• W2894524500 cites W2117057656 @default.
• W2894524500 cites W2124620553 @default.
• W2894524500 cites W2126543110 @default.
• W2894524500 cites W2128024120 @default.
• W2894524500 cites W2131526429 @default.
• W2894524500 cites W2135704068 @default.
• W2894524500 cites W2137837290 @default.
• W2894524500 cites W2146536851 @default.
• W2894524500 cites W2151241130 @default.
• W2894524500 cites W2152901042 @default.
• W2894524500 cites W2399407695 @default.
• W2894524500 cites W2894524500 @default.
• W2894524500 cites W4240986128 @default.
• W2894524500 cites W4379509525 @default.
• W2894524500 doi "https://doi.org/10.1111/jdi.12944" @default.
• W2894524500 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6497594" @default.
• W2894524500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30267620" @default.
• W2894524500 hasPublicationYear "2018" @default.
• W2894524500 type Work @default.
• W2894524500 sameAs 2894524500 @default.
• W2894524500 citedByCount "32" @default.
• W2894524500 countsByYear W28945245002019 @default.
• W2894524500 countsByYear W28945245002020 @default.
• W2894524500 countsByYear W28945245002021 @default.
• W2894524500 countsByYear W28945245002022 @default.
• W2894524500 countsByYear W28945245002023 @default.
• W2894524500 crossrefType "journal-article" @default.
• W2894524500 hasAuthorship W2894524500A5016811241 @default.
• W2894524500 hasAuthorship W2894524500A5017181473 @default.
• W2894524500 hasAuthorship W2894524500A5020894018 @default.
• W2894524500 hasAuthorship W2894524500A5034851576 @default.
• W2894524500 hasAuthorship W2894524500A5041896485 @default.
• W2894524500 hasAuthorship W2894524500A5050955864 @default.
• W2894524500 hasAuthorship W2894524500A5063831864 @default.
• W2894524500 hasAuthorship W2894524500A5066611740 @default.
• W2894524500 hasAuthorship W2894524500A5076190542 @default.
• W2894524500 hasBestOaLocation W28945245002 @default.
• W2894524500 hasConcept C126322002 @default.
• W2894524500 hasConcept C134018914 @default.
• W2894524500 hasConcept C2777180221 @default.
• W2894524500 hasConcept C2777391703 @default.
• W2894524500 hasConcept C2778535154 @default.
• W2894524500 hasConcept C2779306644 @default.
• W2894524500 hasConcept C2779668308 @default.
• W2894524500 hasConcept C3018667095 @default.
• W2894524500 hasConcept C555293320 @default.
• W2894524500 hasConcept C71924100 @default.
• W2894524500 hasConceptScore W2894524500C126322002 @default.
• W2894524500 hasConceptScore W2894524500C134018914 @default.
• W2894524500 hasConceptScore W2894524500C2777180221 @default.
• W2894524500 hasConceptScore W2894524500C2777391703 @default.
• W2894524500 hasConceptScore W2894524500C2778535154 @default.
• W2894524500 hasConceptScore W2894524500C2779306644 @default.
• W2894524500 hasConceptScore W2894524500C2779668308 @default.
• W2894524500 hasConceptScore W2894524500C3018667095 @default.
• W2894524500 hasConceptScore W2894524500C555293320 @default.
• W2894524500 hasConceptScore W2894524500C71924100 @default.
• W2894524500 hasIssue "3" @default.
• W2894524500 hasLocation W28945245001 @default.
• W2894524500 hasLocation W28945245002 @default.
• W2894524500 hasLocation W28945245003 @default.
• W2894524500 hasLocation W28945245004 @default.
• W2894524500 hasLocation W28945245005 @default.
• W2894524500 hasOpenAccess W2894524500 @default.
• W2894524500 hasPrimaryLocation W28945245001 @default.

• next